Zacks Investment ResearchThu, 18 Jun 2026 17:00:40 GMTAtea Pharmaceuticals (AVIR) Upgraded to Buy: Here's What You Should KnowAVIR+0.21%
Zacks Investment ResearchTue, 09 Jun 2026 14:41:19 GMTAre Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?AVIR+0.21%
Seeking AlphaFri, 29 May 2026 15:19:52 GMTAtea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV CatalystAVIR+0.21%
Zacks Investment ResearchFri, 15 May 2026 14:37:17 GMTDown 25% in 4 Weeks, Here's Why Atea Pharmaceuticals (AVIR) Looks Ripe for a TurnaroundAVIR+0.21%
Seeking AlphaWed, 13 May 2026 04:30:46 GMTAtea Pharmaceuticals, Inc. (AVIR) Q1 2026 Earnings Call TranscriptAVIR+0.21%